Concepedia

Steve Wenglowsky

SW

Statistics

Publications

15

Citations

676

H-Index

13

Active since

1991

Affiliations

Array BioPharma (United States)(Current)

Steve Wenglowsky is an author at Array BioPharma (United States) specializing in medicinal chemistry, b-raf inhibitors, and pharmacology.

Publications per year

1991–2022

15

Publications

15

Discovery of Danoprevir (ITMN-191/R7227), a Highly Selective and Potent Inhibitor of Hepatitis C Virus (HCV) NS3/4A Protease

Yutong Jiang, Steven W. Andrews, Kevin R. Condroski et al. · Journal of Medicinal Chemistry · 2013 · 142 citations · Full text

, , +17

Three-Component Intramolecular Two-Alkyne Annulations of Fischer Carbene Complexes: New Strategies for Steroid Synthesis

Jianming Bao, William D. Wulff, Vera Dragisich et al. · Journal of the American Chemical Society · 1994 · 69 citations

, , +13

Pyrazolopyridine Inhibitors of B-Raf<sup>V600E</sup>. Part 1: The Development of Selective, Orally Bioavailable, and Efficacious Inhibitors

Steve Wenglowsky, Li Ren, Kateri A. Ahrendt et al. · ACS Medicinal Chemistry Letters · 2011 · 66 citations · Full text

, , +15

Pyrazolopyridine inhibitors of B-RafV600E. Part 2: Structure–activity relationships

Steve Wenglowsky, Kateri A. Ahrendt, Alex J. Buckmelter et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 56 citations · Full text

, , +13

Biomimetic Macrocycle-Forming Diels−Alder Reaction of an Iminium Dienophile:  Synthetic Studies Directed Toward Gymnodimine

Jeffrey W. Johannes, Steve Wenglowsky, Yoshito Kishi · Organic Letters · 2005 · 55 citations

, , +17

1–5 of 15